Collaborating with Aalto University and Helsinki University on FEPOD project to develop electrochemical sensors to determine analgesic concentrations in blood.
David Savastano, Editor11.18.20
The misuse of opioids is a major concern, as the number of deaths and addictions are rising. According to the US Centers for Disease Control (CDC), of the drug overdose deaths in 2018, “nearly 70% of the 67,367 deaths in 2018 involved an opioid.” Among the CDC’s recommendations is better monitoring of trends.
This could become a reality if the FEPOD project comes to fruition. As part of the Finland Tekes’ Challenge Finland competition, Canatu, Aalto University and the University of Helsinki have developed an electrochemical sensor that utilizes Canatu Carbon NanoBud (CNB) technology to measure bedside blood concentration measurement of analgesics.
Currently, opioid concentration is determined by clinicians’ observations, followed by blood testing. These tests can take hours or even days to process. Using as little as one drop of blood, urine or saliva, FEPOD’s electrochemical sensor will be able
Continue reading this story and get 24/7 access to The Independent Global Source for the Flexible and Printed Electronics Industry. for FREE
Stay ahead of the fast growing field of flexible and printed electronics, an emerging industry that promises to revolutionize the methods in which electronic components and systems are manufactured. Flexible and printed electronics covers smart packaging and labels, sensors and wearables, solar cells, displays and lighting, batteries, medical devices, military equipment, and much more.
FREE SUBSCRIPTION
Already a subscriber? Login